Soft-tissue sarcomas: Overview of management, with a focus on surgical treatment considerations

Cleveland Clinic Journal of Medicine

Volumn 77, Issue SUPPL. 1, 2010, Pages

  Lietman, Steven A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOPSY; GENETICS; HUMAN; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; REVIEW; RISK FACTOR; SARCOMA; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

BIOPSY; HUMANS; MAGNETIC RESONANCE IMAGING; RISK FACTORS; SARCOMA; SENTINEL LYMPH NODE BIOPSY; TREATMENT OUTCOME;

EID: 77953169945     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.77.s1.03     Document Type: Article

References (16)

1. Simon MA, Springfield D, eds. Surgery for Bone and Soft-tissue Tumors. Philadelphia, PA: Lippincott-Raven; 1998.
2. Glencross J, Balasubramanian SP, Bacon J, Robinson MH, Reed MW. An audit of the management of soft tissue sarcoma within a health region in the UK. Eur J Surg Oncol 2003; 29:670-675.
3. Kandel RA, Bell RS, Wunder JS, et al. Comparison between a 2- and 3-grade system in predicting metastatic-free survival in extremity soft-tissue sarcoma. J Surg Oncol 1999; 72:77-82.
4. Suit HD, Spiro I. Role of radiation in the management of adult patients with sarcoma of soft tissue. Semin Surg Oncol 1994; 10:347-356.
5. Suit H, Spiro I. Preoperative radiation therapy for patients with sarcoma of the soft tissues. Cancer Treat Res 1993; 67:99-105.
6. Suit HD, Mankin HJ, Wood WC, et al. Treatment of the patient with stage M0 soft tissue sarcoma. J Clin Oncol 1988; 6:854-862.
7. Fletcher CDM, Unni KK, Mertens F. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Lyon, France: IARC Press; 2002.
8. Brennan MF, Singer S, Maki RG, O'Sullivan B. Sarcomas of the soft tissue and bone. In: DeVita Jr VT, Lawrence TS, Rosenbert SA, eds. Cancer: Principles & Practice of Oncology. 8th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
9. Weiss SW, Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. 5th ed. Philadelphia, PA: Mosby Elsevier; 2008.
10. Gonzalez KD, Buzin CH, Noltner KA, et al. High frequency of de novo mutations in Li-Fraumeni syndrome. J Med Genet 2009; 46:689-693.
11. Gonzalez KD, Noltner KA, Buzin CH, et al. Beyond Li Fraumeni syndrome: clinical characteristics of families with p53 germline mutations. J Clin Oncol 2009; 27:1250-1256.
12. Modena P, Lualdi E, Facchinetti F, et al. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res 2005; 65:4012-4019.
13. Peabody TD, Simon MA. Principles of staging of soft-tissue sarcomas. Clin Orthop Relat Res 1993; 289:19-31.
14. Fong Y, Coit DG, Woodruff JM, Brennan MF. Lymph node metastasis from soft tissue sarcoma in adults: analysis of data from a prospective database of 1,772 sarcoma patients. Ann Surg 1993; 217:72-77.
15. Potter BK, Adams SC, Pitcher JD Jr, Temple HT. Local recurrence of disease after unplanned excisions of high-grade soft tissue sarcomas. Clin Orthop Relat Res 2008; 466:3093-3100.
16. Mariani L, Miceli R, Kattan MW, et al. Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three-grade system. Cancer 2005; 103:402-408.